Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women

International Journal of Obesity

Volumn 35, Issue 12, 2011, Pages 1511-1519

  Erman, A ^a,b   Veilleux, A ^c   Tchernof, A ^b   Goodyer, C G ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

GH resistance; growth hormone receptor; human female; omental fat; subcutaneous fat

Indexed keywords

GROWTH HORMONE RECEPTOR; MESSENGER RNA;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HORMONE RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IDIOPATHIC DISEASE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT;

ADIPOCYTES; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; OBESITY; OMENTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT; THINNESS;

EID: 84856467002     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.23     Document Type: Article

References (46)

1. Bengtsson BA, Brummer RJ, Eden S, Bosaeus I, Lindstedt G. Body composition in acromegaly: the effect of treatment. Clin Endocrinol (Oxf) 1989; 31: 481-490. (Pubitemid 19238231)
2. Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin Endocrinol (Oxf) 2006; 65: 114-117.
3. Hoffman DM, O'Sullivan AJ, Freund J, Ho KK. Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 1995; 80: 72-77.
4. Ballesteros M, Leung KC, Ross RJ, Iismaa TP, Ho KK. Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues. J Clin Endocrinol Metab 2000; 85: 2865-2871. (Pubitemid 32269165)
5. Jorgensen JOL, Moller L, Krag M, Billestrup N, Christiansen JS. Effects of growth hormone on glucose and fat metabolism in human subjects. Endocrinol Metab Clin North Am 2007; 36: 75-88.
6. Nam SY, Lobie PE. The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obes Rev 2000; 1: 73-86.
7. Wei Y, Rhani Z, Goodyer CG. Characterization of growth hormone receptor messenger ribonucleic acid variants in human adipocytes. J Clin Endocrinol Metab 2006; 91: 1901-1908.
8. Beauregard C, Utz AL, Schaub AE, Nachtigall L, Biller BM, Miller KK et al. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008; 93: 2063-2071. (Pubitemid 351831516)
9. Boot AM, Engels MA, Boerma GJ, Krenning EP, de Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997; 82: 2423-2428. (Pubitemid 27337850)
10. Heffernan MA, Thorburn AW, Fam B, Summers R, Conway-Campbell B, Waters MJ et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. Int J Obes Relat Metab Disord 2001; 25: 1442-1449. (Pubitemid 32977859)
11. Kamel A, Margery V, Norstedt G, Thoren M, Lindgren AC, Bronnegard M et al. Growth hormone (GH) treatment up-regulates GH receptor mRNA levels in adipocytes from patients with GH deficiency and Prader-Willi syndrome. Pediatr Res 1995; 38: 418-421.
12. Mekala KC, Tritos NA. Effects of recombinant human growth hormone therapy in obesity in adults: a metaanalysis. J Clin Endocrinol Metab 2009; 94: 130-137.
13. Goodyer CG, Figueiredo RM, Krackovitch S, De Souza LL, Manalo JA, Zogopoulos G. Characterization of the growth hormone receptor in human dermal fibroblasts and liver during development. Am J Physiol Endocrinol Metab 2001; 281: E1213-E1220. (Pubitemid 34001196)
14. Goodyer CG, Zogopoulos G, Schwartzbauer G, Zheng H, Hendy GN, Menon RK. Organization and evolution of the human growth hormone receptor gene 50-flanking region. Endocrinology 2001; 142: 1923-1934. (Pubitemid 32405950)
15. Zou L, Menon RK, Sperling MA. Induction of mRNAs for the growth hormone receptor gene during mouse 3T3-L1 preadipocyte differentiation. Metabolism 1997; 46: 114-118. (Pubitemid 27052034)
16. Ross RJM, Esposito N, Shen XY, Von Laue S, Chew SL, Dobson PRM et al. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the fulllength receptor and generates large amounts of binding protein. Mol Endocrinol 1997; 11: 265-274.
17. Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 2008; 32: 283-291. (Pubitemid 351271776)
18. Morisset AS, Huot C, Legare D, Tchernof A. Circulating IL-6 concentrations and abdominal adipocyte isoproterenol-stimulated lipolysis in women. Obesity (Silver Spring) 2008; 16: 1487-1492. (Pubitemid 351915113)
19. Blouin K, Nadeau M, Mailloux J, Daris M, Lebel S, Luu-The Vet al. Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis. Am J Physiol Endocrinol Metab 2009; 296: E244-E255.
20. Luu-The V, Paquet N, Calvo E, Cumps J. Improved real-time RTPCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 2005; 38: 287-293. (Pubitemid 40216386)
21. Blouin K, Blanchette S, Richard C, Dupont P, Luu-The V, Tchernof A. Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women. Am J Physiol Endocrinol Metab 2005; 288: E398-E404. (Pubitemid 40110649)
22. LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2007; 3: 302-310.
23. Rasmussen MH, Ho KK, Kjems L, Hilsted J. Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss. J Clin Endocrinol Metab 1996; 81: 1519-1524. (Pubitemid 26118586)
24. Roelen CA, Koppeschaar HP, de Vries WR, Snel YE, Doerga ME, Zelissen PM et al. Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein. J Clin Endocrinol Metab 1997; 82: 760-764. (Pubitemid 27106583)
25. Bouhours-Nouet N, Gatelais F, Boux de CF, Rouleau S, Coutant R. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. J Clin Endocrinol Metab 2007; 92: 629-635.
26. Gleeson HK, Lissett CA, Shalet SM. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab 2005; 90: 1061-1067. (Pubitemid 40279234)
27. Fisker S, Hansen B, Fuglsang J, Kristensen K, Ovesen P, Orskov H et al. Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GHbinding protein. Eur J Endocrinol 2004; 150: 773-777. (Pubitemid 38961649)
28. Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P et al. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab 1996; 81: 1575-1581.
29. Higami Y, Pugh TD, Page GP, Allison DB, Prolla TA, Weindruch R. Adipose tissue energy metabolism: altered gene expression profile of mice subjected to long-term caloric restriction. FASEB J 2004; 18: 415-417.
30. Zhang Z, Li Q, Liu F, Sun Y, Zhang J. Prevention of diet-induced obesity by safflower oil: insights at the levels of PPAR{alpha}, Orexin, and Ghrelin ge. Acta Biochim Biophys Sin 2010; 42: 202-209.
31. Kopchick JJ, Andry JM. Growth hormone (GH), GH receptor, and signal transduction. Mol Genet Metab 2000; 71: 293-314.
32. Cali AM, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab 2008; 93(Suppl 1): S31-S36.
33. Denson LA, Menon RK, Shaufl A, Bajwa HS, Williams CR, Karpen SJ. TNF-alpha downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding. J Clin Invest 2001; 107: 1451-1458. (Pubitemid 32522039)
34. Thimmarayappa J, Sun J, Schultz LE, Dejkhamron P, Lu C, Giallongo A et al. Inhibition of growth hormone receptor gene expression by saturated fatty acids: role of Kruppel-like zinc finger factor, ZBP-89. Mol Endocrinol 2006; 20: 2747-2756.
35. Mauriege P, Despres JP, Prud'homme D, Pouliot MC, Marcotte M, Tremblay A et al. Regional variation in adipose tissue lipolysis in lean and obese men. J Lipid Res 1991; 32: 1625-1633.
36. Fain JN. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010; 2010: 513948.
37. Mericq V, Medina P, Bouwman C, Johnson MC, Godoy J, Lopez T et al. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children. Horm Res 2009; 71: 89-93.
38. Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab 1992; 75: 15-20.
39. Marcus C, Bolme P, Micha-Johansson G, Margery V, Bronnegard M. Growth hormone increases the lipolytic sensitivity for catecholamines in adipocytes from healthy adults. Life Sci 1994; 54: 1335-1341. (Pubitemid 24131426)
40. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240-2247. (Pubitemid 46997129)
41. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 1993; 42: 1519-1523. (Pubitemid 24001166)
42. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson BA. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993; 13: 296-301. (Pubitemid 23056803)
43. Garry P, Collins P, Devlin JG. An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. Eur J Endocrinol 1996; 134: 61-66. (Pubitemid 26037108)
44. Bansch D, Dirkes-Kersting A, Schulte H, Assmann G, von Eckardstein A. Basal growth hormone levels are positively correlated with high-density lipoprotein cholesterol levels in women. Metabolism 1997; 46: 1039-1043. (Pubitemid 27371821)
45. Bansch D, Chen-Haudenschild C, Dirkes-Kersting A, Schulte H, Assmann G, von EA. Basal growth hormone levels in women are positively correlated with high-density lipoprotein cholesterol and apolipoprotein A-I independently of insulin-like growth factor 1 or insulin. Metabolism 1998; 47: 339-344. (Pubitemid 28108785)
46. Kenth G, Mergelas J, Goodyer C. Developmental changes in the human growth hormone receptor and its signal transduction pathways. J Endocrinol 2008; 198: 71-82. (Pubitemid 352038186)